Targeting the HPGDS-PGD axis to treat Th17 cell-mediated autoimmunity in multiple sclerosis.

Zhuang Y, Lei K, Li Y, Deng W, Yue J, Wan J, Wu Q, Lu Q, Tang Y, Rasko JEJ, et al.

Signal Transduct Target Ther. 2026 Oct 01; 11(1). PMID: 42816471. Abstract